Gastric preneoplastic lesions and epithelial dysplasia.

[1]  A. Fischer,et al.  Dysplasia and carcinoma in the Billroth II resected stomach 27-35 years post-operatively. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[2]  A. Rosman,et al.  Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome. , 2008, The American journal of cardiology.

[3]  M. Gail,et al.  Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. , 2006, Journal of the National Cancer Institute.

[4]  D. Faigel,et al.  ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. , 2006, Gastrointestinal endoscopy.

[5]  M. Rugge,et al.  Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy , 2005, Journal of Clinical Pathology.

[6]  D. Huntsman,et al.  Gastric cancer: New genetic developments , 2005, Journal of surgical oncology.

[7]  M. Farthing,et al.  Cyclooxygenase 2, p53, beta-catenin, and APC protein expression in gastric adenomatous polyps. , 2005, American journal of clinical pathology.

[8]  H. Sugimura,et al.  A novel STK11 germline mutation in two siblings with Peutz–Jeghers syndrome complicated by primary gastric cancer , 2004, Clinical genetics.

[9]  F. Chan,et al.  Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication , 2004, Gut.

[10]  C. Caldas,et al.  Model of the early development of diffuse gastric cancer in E‐cadherin mutation carriers and its implications for patient screening , 2004, The Journal of pathology.

[11]  M. Ikegami,et al.  Long-term follow-up study of gastric adenoma/dysplasia. , 2004, Endoscopy.

[12]  M. Rugge,et al.  Non-invasive neoplasia of the stomach , 2003, Pathologica.

[13]  G. Jenkins,et al.  Detection of p53 mutations in precancerous gastric tissue , 2003, British Journal of Cancer.

[14]  M. Rasmussen,et al.  Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study , 2003, European journal of gastroenterology & hepatology.

[15]  Tsung-Teh Wu,et al.  Genetic Alterations in Gastric Adenomas of Intestinal and Foveolar Phenotypes , 2003, Modern Pathology.

[16]  M. Rugge,et al.  The long term outcome of gastric non-invasive neoplasia , 2003, Gut.

[17]  O. Nyrén,et al.  Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia , 2003, Gut.

[18]  K. Haruma,et al.  The long‐term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis , 2003, Alimentary pharmacology & therapeutics.

[19]  Hwoong-Yong Jung,et al.  Profile of Aberrant CpG Island Methylation Along the Multistep Pathway of Gastric Carcinogenesis , 2003, Laboratory Investigation.

[20]  J. Jónasson,et al.  Spasmolytic Polypeptide-Expressing Metaplasia (SPEM) Associated with Gastric Cancer in Iceland , 2003, Digestive Diseases and Sciences.

[21]  L. Gong,et al.  Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. , 2003, World journal of gastroenterology.

[22]  Jun Yu,et al.  Promoter hypermethylation of tumor‐related genes in gastric intestinal metaplasia of patients with and without gastric cancer , 2002, International journal of cancer.

[23]  H. Kirikoshi,et al.  Expression of TFF1, TFF2 and TFF3 in gastric cancer. , 2002, International journal of oncology.

[24]  M. Teh,et al.  Study of p53 immunostaining in the gastric epithelium of cagA‐positive and cagA‐negative Helicobacter pylori gastritis , 2002, Cancer.

[25]  Min-Cheol Lee,et al.  Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. , 2002, The American journal of pathology.

[26]  M. Rugge,et al.  Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading , 2002, Alimentary pharmacology & therapeutics.

[27]  Li Dong Wang,et al.  Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features , 2002, BMC Cancer.

[28]  W. Kim,et al.  Epstein-Barr virus, p53 protein, and microsatellite instability in the adenoma-carcinoma sequence of the stomach. , 2002, Human pathology.

[29]  K. Kondo.  Duodenogastric reflux and gastric stump carcinoma , 2002, Gastric Cancer.

[30]  D. Graham,et al.  Patterns of gastric atrophy in intestinal type gastric carcinoma , 2002, Cancer.

[31]  A. Sigurdsson,et al.  The long term results of endoscopic surveillance of premalignant gastric lesions , 2002, Gut.

[32]  T. Nakajima.  Gastric cancer treatment guidelines in Japan , 2002, Gastric Cancer.

[33]  P. Pharoah,et al.  Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. , 2001, Gastroenterology.

[34]  D. Graham,et al.  Gastric intestinal metaplasia: subtypes and natural history. , 2001, Journal of clinical pathology.

[35]  J. Jass,et al.  Altered mucin expression in the gastrointestinal tract: a review , 2001, Journal of cellular and molecular medicine.

[36]  T. Itoh,et al.  Intraglandular necrotic debris in gastric biopsy and surgical specimens. , 2001, Annals of diagnostic pathology.

[37]  W. H. Kim,et al.  CpG island methylation in premalignant stages of gastric carcinoma. , 2001, Cancer research.

[38]  D. Taupin,et al.  Augmented Intestinal Trefoil Factor (TFF3) and Loss of pS2 (TFF1) Expression Precedes Metaplastic Differentiation of Gastric Epithelium , 2001, Laboratory Investigation.

[39]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[40]  B. Crotty,et al.  Risk of gastric cancer is not increased after partial gastrectomy , 2000 .

[41]  D. Graham,et al.  Topographic patterns of intestinal metaplasia and gastric cancer. , 2000 .

[42]  H. Ishii,et al.  Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis , 2000, British Journal of Cancer.

[43]  M. Rugge,et al.  Gastric dysplasia: the Padova international classification. , 2000, The American journal of surgical pathology.

[44]  D. Graham,et al.  Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. , 2000, The American journal of pathology.

[45]  R. Seruca,et al.  Microsatellite instability in hyperplastic and adenomatous polyps of the stomach , 1999, Cancer.

[46]  J. Misdraji,et al.  Gastric epithelial dysplasia , 1999, Gut.

[47]  M. Baek,et al.  Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[48]  T. D. Jenkins.  Atlas of tumor pathology, tumors of the esophagus and stomach , 1999 .

[49]  W. Chey,et al.  Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis , 1999, American Journal of Gastroenterology.

[50]  R. Poulsom,et al.  Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[51]  M. P. Leòn,et al.  Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. , 1999, Italian journal of gastroenterology and hepatology.

[52]  Stolte,et al.  Observer agreement on the grading of gastric atrophy , 1999, Histopathology.

[53]  A. Rashid,et al.  Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. , 1998, The American journal of surgical pathology.

[54]  M. Asaka,et al.  What role does Helicobacter pylori play in gastric cancer? , 1997, Gastroenterology.

[55]  M. Tatematsu,et al.  Gastric and intestinal mixed and solely intestinal types of intestinal metaplasia in the human stomach , 1997, Pathology international.

[56]  A. Axon,et al.  Early gastric cancer in Europe , 1997, Gut.

[57]  M. Leppert,et al.  Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. , 1997, Gastroenterology.

[58]  N. Goldstein,et al.  Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. , 1997, Human pathology.

[59]  S. Nishizuka,et al.  ALLELOTYPE OF ADENOMA AND DIFFERENTIATED ADENOCARCINOMA OF THE STOMACH , 1996, The Journal of pathology.

[60]  J. Virtamo,et al.  Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study. , 1996, Journal of clinical pathology.

[61]  G. Ginsberg,et al.  Gastric polyps: relationship of size and histology to cancer risk. , 1996, The American journal of gastroenterology.

[62]  M. Chung,et al.  Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. , 1996, Cancer research.

[63]  C. O'Morain,et al.  Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. , 1996, Gut.

[64]  M. Rugge,et al.  Gastric epithelial dysplasia. How clinicopathologic background relates to management , 1995, Cancer.

[65]  G. Tamura,et al.  The sequential accumulation of genetic alterations characteristic of the colorectal adenoma–carcinoma sequence does not occur between gastric adenoma and adenocarcinoma , 1995, The Journal of pathology.

[66]  M. Fujishima,et al.  Possible neoplastic transformation within gastric hyperplastic polyp , 1995, Surgical Endoscopy.

[67]  G. Williams,et al.  Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa. , 1994, Gut.

[68]  N. Goldstein,et al.  Gastric dysplasia and its management. , 1994, Gastroenterology.

[69]  C. Fenoglio-Preiser,et al.  The molecular biology of esophageal and gastric cancer and their precursors: oncogenes, tumor suppressor genes, and growth factors. , 1994, Human pathology.

[70]  D. Antonioli.  Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. , 1994, Human pathology.

[71]  G. Stemmermann.  Intestinal metaplasia of the stomach. A status report , 1994, Cancer.

[72]  M. Rugge,et al.  p53 alteration in gastric precancerous lesions. , 1994, The American journal of pathology.

[73]  M. Satoh,et al.  Mutations of the APC gene occur during early stages of gastric adenoma development. , 1994, Cancer research.

[74]  S. Wahl,et al.  p53 expression in precancerous gastric lesions: an immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. , 1993, The American journal of gastroenterology.

[75]  C. di Gregorio,et al.  Gastric dysplasia. A follow-up study. , 1993, The American journal of gastroenterology.

[76]  Y. Furukawa,et al.  Somatic mutations of the APC gene in precancerous lesion of the stomach. , 1993, Human molecular genetics.

[77]  R. Seruca,et al.  Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family , 1993 .

[78]  A. Cuschieri,et al.  Expression of P53 protein in normal, dysplastic, and malignant gastric mucosa: An immunohistochemical study , 1993, The Journal of pathology.

[79]  D. Forman,et al.  An international association between Helicobacter pylori infection and gastric cancer , 1993 .

[80]  R. Fiocca,et al.  Clinical Significance of Gastric Dysplasia: A Multicenter Follow-Up Study , 1993, Endoscopy.

[81]  M. Rugge,et al.  Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1993, Endoscopy.

[82]  W. Blot,et al.  Precancerous gastric lesions in a population at high risk of stomach cancer. , 1993, Cancer research.

[83]  R. Takahashi,et al.  Infrequent ras Mutation in Human Stomach Cancers , 1993, Japanese journal of cancer research : Gann.

[84]  M. Rugge,et al.  Immunohistochemical evidence of p53 overexpression in gastric epithelial dysplasia. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[85]  T. A. Goedde,et al.  Gastroduodenal polyps in familial adenomatous polyposis. , 1992, Surgical oncology.

[86]  Robert Bigelow,et al.  A status report , 1992, Comput. Law Secur. Rev..

[87]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[88]  M. Blaser,et al.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.

[89]  M. Rugge,et al.  Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1991, Human pathology.

[90]  L. Sobin,et al.  Dysplasia of the stomach and Barrett esophagus: a follow-up study. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[91]  J. Misdraji,et al.  Reply , 1991, Gut.

[92]  S. Hirohashi,et al.  Point Mutation of c‐Ki‐ras Oncogene in Gastric Adenoma and Adenocarcinoma with Tubular Differentiation , 1991, Japanese journal of cancer research : Gann.

[93]  M. Kikuchi,et al.  Changes in gastric mucosa that antedate gastric carcinoma , 1990, Cancer.

[94]  A. Spigelman,et al.  Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients. , 1990, Journal of clinical pathology.

[95]  M F Dixon,et al.  High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. , 1990, Gut.

[96]  Richard L. Abbott,et al.  A Follow-up Study , 1990 .

[97]  A. Spigelman,et al.  UPPER GASTROINTESTINAL CANCER IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS , 1989, The Lancet.

[98]  P. Correa,et al.  A human model of gastric carcinogenesis. , 1988, Cancer research.

[99]  L. Ghandur-Mnaymneh,et al.  Dysplasia of Nonmetaplastic Gastric Mucosa: A Proposal for its Classification and its Possible Relationship to Diffuse‐Type Gastric Carcinoma , 1988, The American journal of surgical pathology.

[100]  M. Fujishima,et al.  Natural history of gastric adenomas in patients with familial adenomatosis Coli/Gardner's syndrome , 1988, Cancer.

[101]  D. Gardiol,et al.  Gastric Dysplasia: A Histological Follow-up Study , 1987, The American journal of surgical pathology.

[102]  M. Sivak,et al.  Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps. , 1987, Gut.

[103]  S. Sciallero,et al.  The clinical significance of gastric epithelial dysplasia. , 1986, Endoscopy.

[104]  F. L. Greene.  Precursors of gastric cancer , 1986 .

[105]  D. Henson,et al.  The Pathology of Incipient Neoplasia , 1986 .

[106]  M. Fujishima,et al.  Natural history of fundic gland polyposis in patients with familial adenomatosis coli/Gardner's syndrome. , 1985, Gastroenterology.

[107]  E. Shemesh,et al.  A prospective evaluation of the upper gastrointestinal tract and periampullary region in patients with Gardner syndrome. , 1985, The American journal of gastroenterology.

[108]  T. Hattori.  Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. , 1985, Journal of clinical pathology.

[109]  R. Coffey,et al.  Gastric adenocarcinoma complicating Gardner's syndrome in a North American woman. , 1985, Gastroenterology.

[110]  P. Correa.  Clinical implications of recent developments in gastric cancer pathology and epidemiology. , 1985, Seminars in oncology.

[111]  S. Bülow,et al.  Gastroduodenal polyps in familial polyposis coli , 1985, Diseases of the colon and rectum.

[112]  N. Muñoz,et al.  Gastric dysplasia. Significance and pathologic criteria , 1984, Cancer.

[113]  P. Sipponen,et al.  Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. , 1984, British Journal of Cancer.

[114]  Randall G. Lee,et al.  Upper Gastrointestinal Polyps in Gardner's Syndrome , 1984 .

[115]  P. Cotton,et al.  Gastroscopic screening in 80 patients with pernicious anaemia. , 1983, Gut.

[116]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[117]  R. Brown,et al.  Intramucosal carcinoma of the gastric antrum complicating Menetrier's disease. , 1983, Journal of clinical pathology.

[118]  J. Jass,et al.  A classification of gastric dysplasia , 1983, Histopathology.

[119]  H. Asakura,et al.  Histoclinical long-standing follow-up study of hyperplastic polyps of the stomach. , 1981, The American journal of gastroenterology.

[120]  J. Jass.  Role of intestinal metaplasia in the histogenesis of gastric carcinoma. , 1980, Journal of clinical pathology.

[121]  T. Hirota,et al.  Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. , 1980, Journal of the National Cancer Institute.

[122]  M. Enjoji,et al.  Gastric lesions in familial adenomatosis coli: their incidence and histologic analysis. , 1978, Human pathology.

[123]  T. Iwama,et al.  Gastric lesion of familial polyposis coli , 1974, Cancer.

[124]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[125]  A. H. Harkness,et al.  Oral penicillin in gonorrhoea. , 1946, Lancet.

[126]  T. Nakajima,et al.  Gastric adenoma — carcinoma sequence with special reference to p53 and Ki-ras gene alterations , 2004, Virchows Archiv.

[127]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[128]  H. Sugimura,et al.  Microsatellite instability and K-ras mutations in gastric adenomas, with reference to associated gastric cancers. , 1999, Cancer detection and prevention.

[129]  D. Forman.  Helicobacter pylori and gastric cancer. , 1996, Scandinavian journal of gastroenterology. Supplement.

[130]  M. Merino,et al.  LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions. Prognostic implications. , 1996, Pathology, research and practice.

[131]  T. Sawada,et al.  Familial Adenomatous Polyposis: Should Patients Undergo Surveillance of the Upper Gastrointestinal Tract? , 1995, Endoscopy.

[132]  I. Bearzi,et al.  Gastric dysplash: A ten-year follow-up study , 1994 .

[133]  Y.-C. Zhang.  Typing and Grading of Gastric Dysplasia , 1993 .

[134]  K. Kawai,et al.  Precancerous Conditions and Lesions of the Stomach , 1993, Springer Berlin Heidelberg.

[135]  M. Hill.  Epidemiology and Mechanism of Gastric Carcinogenesis , 1990 .

[136]  L. Sobin,et al.  Precancerous lesions of the gastrointestinal tract : a histological classification , 1985 .

[137]  P. Correa.  The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. , 1980, Frontiers of gastrointestinal research.

[138]  W. Oehlert,et al.  Gastric mucosal dysplasia: what is its clinical significance? , 1979, Frontiers of gastrointestinal research.

[139]  A. Serck-Hanssen.  Precancerous lesions of the stomach. , 1979, Scandinavian journal of gastroenterology. Supplement.

[140]  E. Grundmann.  Histologic types and possible initial stages in early gastric carcinoma. , 1975, Beitrage zur Pathologie.